What we do

For more than 45 years we’ve been creating high-quality medicines and making them accessible to the people who need them.

Learn more about how we do this across North America, MENA and Europe.

Investors

Together we are building a leading generics and specialty pharmaceutical company where everyone can thrive.

Learn more about our strategy, investment case and track record of success.

Responsibility

Learn more about how we put better health within reach, every day and make a difference to people’s lives.

Careers

We're looking for people who share our passion and want to help us make a real difference in the world.

Newsroom

Featured

Press Release, Financial Results 26 February 2025

Hikma receives FDA approval and launches Mercaptopurine Oral Suspension in the US Press Release, Product 27 February 2025 Hikma receives FDA approval and launches Mercaptopurine Oral Suspension in the US
Strong 2024 performance and a positive outlook for 2025 Press Release, Financial Results 26 February 2025 Strong 2024 performance and a positive outlook for 2025
Notice of results Press Release, Financial Results 10 February 2025 Notice of results
Hikma and M42 sign strategic MOU to advance healthcare innovation in the UAE Press Release, Business Development 30 January 2025 Hikma and M42 sign strategic MOU to advance healthcare innovation in the UAE